AABIP Advocacy Statement
Back
CY 2027 Medicare Final Rules: Interventional Pulmonology and Advanced Bronchoscopy Update
Neeraj R Desai MD MBA, Niral Patel MD, Laura Frye MD, Sonali Sethi MD and Carla Lamb MD
On behalf of the AABIP Advocacy Committee
The American Association for Bronchology and Interventional Pulmonology (AABIP) is deeply disappointed that CMS finalized several policies in the 2027 Medicare Physician Fee Schedule that will make it harder for interventional and advanced pulmonary proceduralists to diagnose and treat patients with lung cancer, central airway obstruction, pleural disease, and other complex thoracic conditions.
AABIP urges Congress to enact an inflation-based annual update to Medicare physician payment. It also calls on CMS to work with specialty societies on evidence-based valuation rather than across-the-board cuts.
Highlights
For 2027, Medicare will pay interventional pulmonologists about 2.3% less per RVU in addition to the effect of inflation (3.7% annually as of September 2026). Hospital outpatient payment for bronchoscopy and pleural procedures goes up. Both final rules were released November 4, 2026, and take effect January 1, 2027: the Physician Fee Schedule (CMS-1848-F) and the Hospital Outpatient/ASC rule (CMS-1850-F).
- Professional fees go down. The non-APM conversion factor drops from $33.4009 to $32.6286 (−2.31%).
- A same-day E/M is paid 20% less when it comes with a 0-day-global procedure. Most bronchoscopy, thoracentesis, chest tube and indwelling pleural catheter codes have a 0-day global period. A clinic visit billed with modifier 25 on the same day as one of those procedures, by the same physician or by a same-specialty colleague in the group, is paid at 80%.
- Hospital outpatient payment rises. OPPS gets a 2.3% update. Non-drug services also get a budget-neutrality boost that comes from cutting 340B drug payments to ASP−28%.
- More thoracic procedures can be done as outpatient cases. Respiratory and mediastinal procedures are among the 637 services coming off the inpatient-only list, and 619 services are being added to the ASC list. Expect payers to push more cases out of the inpatient setting.
Physician Fee Schedule: conversion factor and specialty impact
The cut is deeper than CMS proposed in July. The work RVU budget-neutrality adjustment went from +0.53% in the proposal to −0.12% in the final rule. The main driver is the expiration of the one-time 2.5% increase for 2026.
|
Conversion factor
|
2026
|
Proposed 2027
|
Final 2027
|
Change
|
|
Non-qualifying APM (most IP physicians)
|
$33.4009
|
$32.8409
|
$32.6286
|
−2.31%
|
|
Qualifying APM participant
|
$33.5675
|
$33.1693
|
$32.9548
|
−1.83%
|
CMS's estimated specialty impacts below are RVU-only. Each specialty's net change is roughly the figure shown plus the conversion factor change. These figures leave out the same-day E/M reduction, which CMS models separately.
|
Specialty
|
2025 allowed charges ($M)
|
Work RVU
|
PE RVU
|
Combined RVU impact
|
|
Pulmonary disease
|
1,281
|
0%
|
−1%
|
0%
|
|
Critical care
|
353
|
0%
|
−1%
|
−1%
|
|
Thoracic surgery
|
301
|
0%
|
0%
|
0%
|
|
Interventional radiology (for comparison)
|
553
|
0%
|
+3%
|
+3%
|
|
Anesthesiology
|
1,672
|
0%
|
0%
|
0%
|
In practice, a hospital-based IP physician who isn't a qualifying APM participant should plan for about a 2.3–3.3% drop in Medicare professional revenue per procedure.
Physician Fee Schedule: policies that impact IP procedures
For procedures, the main things to know are the modifier 25 reduction, the 2026 hospital-based cuts that carry forward, and a new practice expense formula.
Same-day E/M with a 0-day-global procedure (new). The policy applies to office/outpatient E/M visits (99202–99205, 99211–99215) billed with modifier 25 on the same day as a 0-day-global procedure. It applies when the same physician performs both, or a physician of the same specialty in the same group. The higher-valued service is paid at 100% and the other at 80%. CMS had proposed paying the other service at 50% and extending the policy to 10- and 90-day globals; the final rule dropped both. Inpatient, emergency, critical care and nursing facility visits are excluded.
- Scenario: a new outpatient with lung nodule visit billed with -25 on the same day as Robotic bronchoscopy, EBUS. The bronchoscopy usually has the higher value, so the E/M is the service paid at 80%.
- Bronchoscopy done the same day by a different specialty, such as thoracic surgery, isn't affected.
- Inpatient same day procedure and consultation/progress note is not affected
New practice expense formula. CMS finalized these changes:
- Indirect PE is now allocated on both work RVUs and clinical labor RVUs, rather than whichever is larger. This applies to all codes except 10- and 90-day globals. Office-based pleural work that uses a lot of clinical staff (thoracentesis, IPC placement) may gain. Facility-only codes may give up a little.
- The indirect practice cost index (IPCI) is phased out over two years: half in 2027 and the rest in 2028.
- A stabilizer limits year-over-year changes in a code's PE RVUs to 5% for most existing codes. It doesn't apply to new, revised or revalued codes.
Facility indirect practice expense (carried over from 2026). Facility-setting services still get 50% of the indirect PE per work RVU that office services get. Almost all advanced bronchoscopy is performed in a facility, so this is the policy that weighs most on IP professional fees. CMS asked whether hospital-employed physicians have even lower overhead and whether a modifier should identify them. Nothing was finalized for 2027, but this is a risk in future rules for employed IP groups.
Physician Fee Schedule: clinic visits, telehealth and teaching
For the IP clinic, G2211 is replaced by a modifier, telehealth flexibilities run through 2027, and teaching physicians get more room for virtual presence.
- G2211 is retired and replaced by modifier B1. B1 raises the E/M payment by 16% at every visit level. It fits longitudinal IP care such as nodule surveillance, malignant effusion and airway stenosis. Modifier B2 raises the E/M payment by 32%, but only for clinicians in an MSSP or LEAD ACO. B2 is voluntary and can be billed for any Medicare patient. The revenue will still flow to practices under that proposal, but Unlike G2211 No RVU credit it will not be attributable to individual clinicians via relative value units (RVUs), complicating compensation decisions.
- Telehealth. Medicare telehealth flexibilities, including audio-only visits and the home as an originating site, are extended through December 31, 2027. New payment-neutral modifiers start January 1, 2027: BB for virtual-platform services and BC for services furnished incident-to
- Teaching physicians. A teaching physician can bill for a service involving a resident when either the teaching physician or the resident is physically with the patient. This is relevant to IP fellowship clinics.
Hospital outpatient and ASC rule (CMS-1850-F)
Hospital outpatient payment for bronchoscopy and pleural procedures goes up in 2027 for most hospitals. The rule has no bronchoscopy-specific policy changes; the only pulmonary-specific item is the inpatient-only list removals
|
Provision
|
Final 2027 policy
|
What it means for IP
|
|
Payment update
|
+2.3% for OPPS and ASC (3.2% market basket − 0.9 productivity)
|
Higher facility rates for airway endoscopy and pleural APCs
|
|
Inpatient-only list
|
637 services removed in year 2 of 3, including the respiratory and mediastinum/diaphragm families; the rest come off in CY 2028
|
More thoracic and airway procedures can be paid as outpatient. Payers may deny inpatient stays, so document medical necessity
|
|
ASC covered procedures
|
619 services added (618 proposed)
|
Some IP and thoracic codes may become ASC-eligible. Check Addendum AA
|
|
Prior authorization
|
Expanded only to 8 botulinum toxin codes (from July 1, 2027)
|
No new prior auth for bronchoscopy or pleural procedures
|
Code-level quick reference
This table maps the 2027 policies onto common IP code families. Global periods are standard CMS assignments; confirm them and the 2027 RVUs in the final rule Addendum B before modeling.
|
Code family
|
Examples
|
Global
|
2027 PFS effects
|
2027 OPPS effects
|
|
Diagnostic and biopsy bronchoscopy
|
31622–31629, 31632–31633
|
0-day
|
CF cut; same-day E/M paid at 80%; 2026 efficiency cut and facility PE cut remain
|
Airway endoscopy APCs get the 2.3% update and the non-drug budget-neutrality gain
|
|
Navigation and EBUS
|
+31627, 31652–31653, +31654
|
0-day / add-on
|
Same as above; add-ons are not subject to the E/M reduction themselves
|
Add-ons packaged; check 2027 status of the hospital-only C-code combinations
|
|
Therapeutic airway
|
31630–31641, 31645, 31647–31651, 31660–31661
|
0-day
|
Same as above
|
Same as above
|
|
Pleural drainage
|
32554–32557 (thoracentesis), 32550 (IPC), 32551 (chest tube)
|
0-day
|
Same-day E/M paid at 80%; new PE formula may help in-office placement
|
Imaging-guided cases unaffected by the site-neutral imaging policy (that covers standalone non-contrast imaging)
|
|
IPC removal
|
32552
|
10-day
|
E/M reduction doesn't apply; global revaluation risk
|
—
|
|
Medical thoracoscopy
|
32601 (diagnostic), 32650 (with pleurodesis)
|
0-day / 90-day
|
32601: E/M reduction applies. 32650: global revaluation risk
|
Some VATS-family codes come off the inpatient-only list
|
|
Clinic E/M
|
99202–99215
|
—
|
B1 (+16%) replaces G2211; B2 (+32%) for ACO clinicians
|
Off-campus clinic visits remain site-neutral (since 2019)
|
|
Critical care
|
99291–99292, G0508–G0509
|
—
|
Excluded from the E/M reduction; specialty −1%
|
—
|
Fine needle aspiration RVU changes
|
Code family
|
Examples
|
Global
|
2026 RVU
|
2027 wRVU
|
|
Fine Needle Aspiration
|
10005
Fine needle aspiration biopsy, including ultrasound guidance; first lesion
|
N/A
|
1.42 wRVU
1.87 Total Facility RVU
3.96 Total Non-Facility RVU
|
1.35 wRVU
1.77 Total Facility RVU
4.79 Total Non-Facility RVU
|
|
Fine Needle Aspiration
|
10006
Fine needle aspiration biopsy, including ultrasound guidance; each additional lesion)
|
N/A
|
0.98 wRVU
1.29 Total Facility RVU
1.80 Total Non-Facility RVU
|
1.00 wRVU
1.31 Total Facility RVU
3.02 Total Non-Facility RVU
|
Reference:
For additional questions about the CY 2027 Medical Final Rule please contact Dr. Neeraj Desai, Dr. Niral Patel, Dr. Laura Frye, Dr. Sonali Sethi and Dr. Carla Lamb at the [email protected]
11/17/2026
|